描述
发表于 2025-3-26 21:18:53
,p53 in the Clinic: A Pathologist’s View,compared to . status assessed by gene sequencing. This explains why p53 as a biomarker remains not so widely used by pathologists except for several well-defined indications detailed in this chapter. P63, a member of the p53 family, is also frequently used in diagnostic pathology as a differentiation marker and will be discussed in this chapter.
最高峰
发表于 2025-3-27 01:53:07
http://reply.papertrans.cn/77/7647/764614/764614_32.png
Flinch
发表于 2025-3-27 09:09:09
Book 2013 advances on the potential application of p53 into the clinics. The goal of this book is to capture these developments and to appeal to a clinical and medical audience beyond the one which was the primary target of "25 years of p53".
BALK
发表于 2025-3-27 11:07:22
978-1-4899-9217-8Springer Science+Business Media New York 2013
nephritis
发表于 2025-3-27 14:20:10
Pierre Hainaut,Magali Olivier,Klas G. WimanFocuses on recent advances in translational research on p53.Explores the significance of the genetic diversity of p53.Discusses mutations as biomarkers in molecular pathology
无辜
发表于 2025-3-27 18:24:08
http://reply.papertrans.cn/77/7647/764614/764614_36.png